WallStreetZenWallStreetZen

NASDAQ: VRTX
Vertex Pharmaceuticals Inc Stock Ownership - Who owns Vertex Pharmaceuticals?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Vertex Pharmaceuticals Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Duncan McKechnieEVP Chief Commercial Officer2026-03-042,437$475.30
$1.16MSell
Joy LiuEVP and Chief Legal Officer2026-03-02892$495.96
$442.40kSell
Reshma KewalramaniCEO President2026-02-273,498$494.33
$1.73MSell
Reshma KewalramaniCEO President2026-02-27400$479.75
$191.90kSell
Reshma KewalramaniCEO President2026-02-27120$481.50
$57.78kSell
Reshma KewalramaniCEO President2026-02-27240$482.84
$115.88kSell
Reshma KewalramaniCEO President2026-02-272,510$487.13
$1.22MSell
Reshma KewalramaniCEO President2026-02-273,278$488.27
$1.60MSell
Reshma KewalramaniCEO President2026-02-27460$489.32
$225.09kSell
Reshma KewalramaniCEO President2026-02-272,725$490.54
$1.34MSell

1 of 14

VRTX insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when VRTX insiders and whales buy or sell their stock.

VRTX Shareholders

What type of owners hold Vertex Pharmaceuticals Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Capital World Investors10.04%25,510,182$11.65BInstitution
Vanguard Group Inc9.49%24,105,823$11.01BInstitution
Blackrock Inc9.35%23,751,989$10.85BInstitution
Capital Research Global Investors6.82%17,316,344$7.91BInstitution
State Street Corp4.60%11,689,539$5.34BInstitution
Jpmorgan Chase Co2.38%6,039,481$2.76BInstitution
Geode Capital Management LLC2.35%5,981,905$2.73BInstitution
Capital International Investors1.86%4,733,596$2.16BInstitution
Alliancebernstein LP1.77%4,496,482$2.05BInstitution
Loomis Sayles Co L P1.59%4,033,525$1.84BInstitution

1 of 3

VRTX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
VRTX92.77%1.52%Net SellingNet Selling
REGN68.82%31.18%Net SellingNet Selling
NVO7.04%0.00%
ARGX48.93%0.00%
ALNY82.40%17.60%Net SellingNet Selling
View Top Biotech Stocks

Vertex Pharmaceuticals Stock Ownership FAQ

Who owns Vertex Pharmaceuticals?

Vertex Pharmaceuticals (NASDAQ: VRTX) is owned by 92.77% institutional shareholders, 1.52% Vertex Pharmaceuticals insiders, and 5.70% retail investors. Capital World Investors is the largest individual Vertex Pharmaceuticals shareholder, owning 25.51M shares representing 10.04% of the company. Capital World Investors's Vertex Pharmaceuticals shares are currently valued at $11.65B.

If you're new to stock investing, here's how to buy Vertex Pharmaceuticals stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.